Administration of chemotherapy with palliative intent in the last 30 days of life: The balance between palliation and chemotherapy

作者: N. Zdenkowski , J. Cavenagh , Y. C. Ku , A. Bisquera , A. Bonaventura

DOI: 10.1111/IMJ.12245

关键词:

摘要: Background Appropriately timed cessation of chemotherapy is an important aspect good quality palliative care. There wide variation in the reported rates administration within last 30 days life. Aims To identify predictors death receiving chemotherapy, and to propose a standard definition by which oncologists cancer centres can be compared. Methods Patients who received at regional centre its rural outreach unit between 2009 2011 were included. An adjusted logistic regression model, including all variables, was fit chemotherapy. Results Over 3-year period, 1131 patients 138 (12%) died chemotherapy. Predictors were: less than contact with care (odds ratio 3.30 (95% confidence interval 2.04–5.34), P < 0.001) male gender 2.02 1.24–3.31), = 0.0049), but treating clinician, tumour chemoresponsiveness, age, body mass index survival from initial diagnosis not. Conclusion Patients life more likely have shorter duration team involvement. In this study, observed rate range published data. It recommended that used benchmark medical oncology individual oncologists, allow comparison over time.

参考文章(34)
Lisa Barbera, Lawrence Paszat, Carole Charter, Indicators of poor quality end-of-life cancer care in Ontario. Journal of Palliative Care. ,vol. 22, pp. 12- 17 ,(2006) , 10.1177/082585970602200103
Andrea Angelo Martoni, Stephan Tanneberger, Vita Mutri, Cancer chemotherapy near the end of life: the time has come to set guidelines for its appropriate use. Tumori. ,vol. 93, pp. 417- 422 ,(2007) , 10.1177/030089160709300502
Jaclyn YOONG, Jo-An SEAH, Katherine HAMILTON, Lee Na TEO, Geoffrey CHONG, Mortality within 30 days of receiving systemic anti-cancer therapy at a regional oncology unit: what have we learned? Asia-pacific Journal of Clinical Oncology. ,vol. 8, pp. 325- 329 ,(2012) , 10.1111/J.1743-7563.2011.01498.X
Eduardo Bruera, Catherine Sweeney, Kathryn Calder, Lynn Palmer, Suzanne Benisch-Tolley, Patient Preferences Versus Physician Perceptions of Treatment Decisions in Cancer Care Journal of Clinical Oncology. ,vol. 19, pp. 2883- 2885 ,(2001) , 10.1200/JCO.2001.19.11.2883
Deepti Behl, Aminah Jatoi, What Do Oncologists Say about Chemotherapy at the Very End of Life? Results from a Semiqualitative Survey Journal of Palliative Medicine. ,vol. 13, pp. 831- 835 ,(2010) , 10.1089/JPM.2009.0414
Sandra G. Zakowski, Casey Harris, Nancy Krueger, Kimberly K. Laubmeier, Susan Garrett, Robert Flanigan, Peter Johnson, Social barriers to emotional expression and their relations to distress in male and female cancer patients British Journal of Health Psychology. ,vol. 8, pp. 271- 286 ,(2003) , 10.1348/135910703322370851
Matthew E. Nilsson, Paul K. Maciejewski, Baohui Zhang, Alexi A. Wright, Elizabeth D. Trice, Anna C. Muriel, Robert J. Friedlander, Karen M. Fasciano, Susan D. Block, Holly G. Prigerson, Mental health, treatment preferences, advance care planning, location,and quality of death in advanced cancer patients with dependent children Cancer. ,vol. 115, pp. 399- 409 ,(2009) , 10.1002/CNCR.24002
R. Asola, H. Huhtala, K. Holli, Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer. Breast Cancer Research and Treatment. ,vol. 100, pp. 77- 82 ,(2006) , 10.1007/S10549-006-9224-X